MBTPS1 and inflammatory bowel disease: This is of particular interest since S1P is well-recognized for its pathophysiological role in inflammatory bowel diseases, and new small molecules modulating S1P receptors are shown to be effective in ameliorating the symptoms in gastrointestinal inflammation [32,33].